Formoterol Fumarate: Medgend

Formoterol Fumarate FDA Approved Drugs

BEVESPI AEROSPHERE [Formoterol Fumarate^{2C₁₉H₂₄N₂O₄C₄H₄O₄2H₂O} : Glycopyrrolate^{C₁₉H₂₈NO₃Br}]

0.0048mg/inh : 0.0090mg/inh (inhalation aerosol, metered)

Astrazeneca Pharms^{Apr 25, 2016}

Use in the long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (copd).

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

DULERA [Formoterol Fumarate^{2C₁₉H₂₄N₂O₄C₄H₄O₄2H₂O} : Mometasone Furoate^{C₂₇H₃₀Cl₂O₆}]

0.005mg/inh : 0.1mg/inh (inhalation aerosol, metered)

0.005mg/inh : 0.2mg/inh (inhalation aerosol, metered)

Merck Sharp Dohme^{Jun 22, 2010}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

PERFOROMIST [Formoterol Fumarate^{2C₁₉H₂₄N₂O₄C₄H₄O₄2H₂O}]

0.02mg/2ml (inhalation solution)

Mylan Speclt^{May 11, 2007}

Maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (copd).

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

SYMBICORT [Budesonide : Formoterol Fumarate Dihydrate]

0.08mg/inh : 0.0045mg/inh (inhalation aerosol, metered)

0.16mg/inh : 0.0045mg/inh (inhalation aerosol, metered)

Astrazeneca^{Jul 21, 2006}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.